HROW Harrow Health Inc

$HROW I’m thinking Harrow’s pre-NDA meeting for G-Melt is this week. Hoping Harrow does a PR after the meeting.

$HROW SYD-101 will be >100M drug. Not massive, but big enough for Harrow. Santen bought rights for RYJUNEA in EU. (you remember who bought stuff from them in US). Sydnexis sold rights for royalties to Ligand for 23M US rights ready for BUYOUT. Nothing else left. Harrow's drug.

$HROW OK, no one can predict the short term share price. Ar some point, it will go much higher than expected. The value of Harrow’s assets will justify a share price north of $200.

$HROW What you think about Q3 revenue. I think 95M. Some people would be disappointed but i think stock would hit this yea $40 bc valuation is ridiculous. Late next year$100. Some investor expects 109.7M for Q3. I am ok with 90M revenue. And Q4 1.4*Q3 = full year 330M. But i would want 95M.

$HROW Next: 🔸MELT NDA (pre-NDA meeting + submission) Q4 🔸BYQLOVI commercial launch Q4 🔸IHEEZO, NATACYN and CR-01 topline data Q4 🔸TRIESENCE topline data Q1 27 🔸Opuviz launch Q1 27 🔸Investor day Q1 27 Bonus: M&A? ⬇️💪

$HROW Two angels visited me in a dream during the night and whispered in my ear, ”NDA to be filed in 2026.”🤗

$HROW do you have any feedback on how the new sales Reps are performing? Any insight on how productive they've been? As expected? Better than expected?

$HROW I’m an optometrist, been using Vevye for a few years. Always was able to get samples when I needed them from my local rep. She and her boss were both fired and now we have a virtual rep. Anyone know if they are cutting back, or is this a local Maryland issue?

$HROW now all the selling makes sense with the boston based fund opaleye unwinding, with an over 100M position in the company.

$HROW Starting Monday, October 5, Harrow is opening up four exciting new opportunities on our sales team. If you're a proven leader in pharma/specialty pharmacy sales, you'll want to keep an eye out 👀 Here's what's coming: ✅ Regional Sales Director – East Coast (2nd line leadership) ✅ Regional Sales Director – West Coast (2nd line leadership) ✅ Area Sales Manager – Northeast (ME, NH, CT + surrounding states) ✅ Area Sales Manager – North Central (IL, WI, IN, MN) These are high-visibility roles for leaders ready to build and drive high-performing teams in a fast-growing specialty pharma company.

$HROW Not surprised Opaleye is done with how much money they made on ETON. They also made a bunch here in the early days, even with this being a total pig as of late, so not surprised they are dumping this as well.

$HROW actually all the critical numbers are better than expected. They just have not been published yet.

$HROW makes sense Oplayea is shutting down if they have a big position in this horrible company

$HROW This is very close to breaking hard to the downside. Can't say I'm sad I only have 1,000 shares left...